Coexisting molar pregnancy

It often refers to a twin pregnancy in which one conception develops as a hydatidiform mole while the other may develop as a fetus with its own placenta. The diagnosis and the choice to continue or end the pregnancy require individual assessment by maternal-fetal medicine and gestational trophoblastic disease specialists.

Molar tissue grows abnormally and produces the pregnancy hormone hCG. Ultrasound may show a developing fetus alongside an abnormal placental mass, but additional imaging and genetic or pathology assessment may be needed to distinguish this from other placental conditions.

Risks to the pregnant person include vaginal bleeding, severe nausea and vomiting, high blood pressure arising unusually early, overactive thyroid effects and abnormal molar tissue that persists after the pregnancy. The fetus may face growth problems, pregnancy loss or early delivery. These possibilities make close observation essential, but they do not determine an individual outcome.

Attend all scheduled ultrasound, blood pressure and blood-test appointments, and use the team's direct contact route if symptoms change. Clinicians may monitor fetal growth, the size and behaviour of molar tissue, hCG patterns, thyroid function, blood count, liver and kidney function, and signs of pregnancy complications.

Discuss both maternal safety and fetal outlook when considering pregnancy management. Ask where urgent assessment and delivery would occur. After the pregnancy ends, serial hCG monitoring is crucial because a plateau or rise can indicate persistent gestational trophoblastic disease; effective contraception may be advised during surveillance so a new pregnancy does not obscure interpretation of hCG.

Seek urgent maternity assessment for vaginal bleeding, severe abdominal pain, fainting, breathlessness, repeated vomiting with inability to keep fluids down, severe headache, visual disturbance, sudden swelling, chest pain or seizures. These symptoms can signal blood loss, blood-pressure complications or other serious problems and should not wait for the next routine visit.

Ask how certain the diagnosis is, whether the fetus and molar tissue have separate placentas, and which findings would change the plan. Clarify how often monitoring is needed, what symptoms require immediate travel to hospital, how delivery or evacuation will be managed, when pathology results are expected, and how hCG follow-up will work afterward.